We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+14.5%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$59B
AUM Growth
+$9.67B
(+20%)
Cap. Flow
+$3.02B
Cap. Flow
% of AUM
5.11%
Top 10 Holdings %
Top 10 Hldgs %
26.45%
Holding
2,790
New
663
Increased
538
Reduced
776
Closed
680
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.43B |
| 2 |
Amazon
AMZN
|
+$601M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$414M |
| 4 |
D.R. Horton
DHI
|
+$305M |
| 5 |
Intel
INTC
|
+$301M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$905M |
| 2 |
NVIDIA
NVDA
|
+$592M |
| 3 |
Advanced Micro Devices
AMD
|
+$439M |
| 4 |
Amgen
AMGN
|
+$385M |
| 5 |
Adobe
ADBE
|
+$382M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.79% |
| 2 | Consumer Discretionary | 13.23% |
| 3 | Healthcare | 12.61% |
| 4 | Financials | 7.44% |
| 5 | Communication Services | 6.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DFTX
2426
Definium Therapeutics
DFTX
$5.73B
| – | – |
-11,545
| Closed | -$36.1K |
|
2427
Monro
MNRO
$525M
| – | – |
-62,194
| Closed | -$1.73M |
|
2428
Altria Group
MO
$122B
| – | – |
-51,636
| Closed | -$2.17M |
|
2429
Molina Healthcare
MOH
$10.3B
| – | – |
-30,305
| Closed | -$9.94M |
|
2430
Morningstar
MORN
$6.56B
| – | – |
-8,000
| Closed | -$1.87M |
|
|
MPT
2431
Medical Properties Trust
MPT
$2.89B
| – | – |
-191,274
| Closed | -$1.04M |
|
|
MRUS
2432
DELISTED
Merus
MRUS
| – | – |
-22,500
| Closed | -$531K |
|
2433
MSCI
MSCI
$40B
| – | – |
-40,014
| Closed | -$20.5M |
|
2434
Meritage Homes
MTH
$4.87B
| – | – |
-4,190
| Closed | -$256K |
|
2435
CALL
Micron Technology
MU
$1.04T
| – | – |
-23,800
| Closed | -$1.62M |
|
2436
McEwen Inc
MUX
$1.03B
| – | – |
-75,165
| Closed | -$489K |
|
2437
Microvision
MVIS
$88.2M
| – | – |
-116,731
| Closed | -$256K |
|
2438
Microvast
MVST
$267M
| – | – |
-102,027
| Closed | -$193K |
|
2439
MYR Group
MYRG
$5.9B
| – | – |
-1,865
| Closed | -$251K |
|
2440
N-able
NABL
$769M
| – | – |
-85,072
| Closed | -$1.1M |
|
2441
Northeast Bank
NBN
$1.11B
| – | – |
-5,241
| Closed | -$231K |
|
2442
Nasdaq
NDAQ
$51.5B
| – | – |
-2,000,144
| Closed | -$97.2M |
|
2443
Neogen
NEOG
$2.05B
| – | – |
-134,738
| Closed | -$2.5M |
|
2444
Neumora Therapeutics
NMRA
$276M
| – | – |
-256,412
| Closed | -$3.62M |
|
|
NNDM
2445
Nano Dimension
NNDM
$309M
| – | – |
-63,492
| Closed | -$173K |
|
2446
Northrop Grumman
NOC
$77B
| – | – |
-15,352
| Closed | -$6.76M |
|
|
NOTE
2447
DELISTED
FiscalNote
NOTE
| – | – |
-2,211
| Closed | -$55.2K |
|
2448
NRG Energy
NRG
$29.8B
| – | – |
-37,613
| Closed | -$1.45M |
|
2449
Nurix Therapeutics
NRIX
$2.43B
| – | – |
-127,509
| Closed | -$1M |
|
2450
Insperity
NSP
$1.85B
| – | – |
-12,300
| Closed | -$1.2M |
|
Similar funds
Marshall Wace's Q4 2023 Portfolio in Review
As of Q4 2023, Marshall Wace held 2,790 positions worth $59B, up 20% from $49.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Marshall Wace deployed $3.02B of net new capital in Q4 2023, opening 663 new positions and adding to 538 existing holdings. Its largest new stake was Qualcomm: 1,674,985 shares worth $242M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Microsoft, an estimated $905M trimmed.
- Marshall Wace's largest Q4 2023 buy was Qualcomm: 1,674,985 shares worth $242M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q4 2023, an estimated $3.43B increase.
- Marshall Wace's biggest Q4 2023 reduction was Microsoft, cutting an estimated $905M.
- Marshall Wace fully exited VMware, Inc in Q4 2023, selling an estimated $149M.
- Marshall Wace's ten largest holdings make up 26% of its $59B portfolio in Q4 2023.
- Marshall Wace opened 663 new positions and closed 680 in Q4 2023.
- Marshall Wace's portfolio value rose 20% quarter-over-quarter to $59B.
Based on Marshall Wace's 13F filing for Q4 2023, filed 14 Feb 2024.